Yushe Dang

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer”.

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.019

N/A

0.113DataRank · unranked

1 citations

Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R. Gwin, Jessica Reichow, Yushe Dang +7 more

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1579

N/A

0DataRank · unranked

20 citations

John B. Liao, Yushe Dang, Andrew L. Coveler, Angela Shaulov Kask, Yi Yang +4 more

Final report and long-term outcomes: Phase I trial of a HER2 intracellular plasmid-based vaccine in HER2+ advanced stage breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2619

N/A

0DataRank · unranked

7 citations

Yushe Dang, Andrew L. Coveler, Doreen M. Higgins, Jennifer S. Childs, Lupe G. Salazar +1 more

Data from Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

(2023)10.1158/1078-0432.c.6531173

N/A

0DataRank · unranked

0 citations

John B. Liao, Yushe Dang, Andrew L. Coveler, Angela Shaulov Kask, Yi Yang +4 more

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

Vaccines(2025)10.3390/vaccines13020117

N/A

0DataRank · unranked

5 citations

Lupe G. Salazar, James Y. Dai, Doreen M. Higgins, Andrew L. Coveler, Jennifer S. Childs +7 more